The abnormal activation of NLRP3 is strongly linked to several chronic inflammatory diseases, such as metabolic syndrome, rheumatoid arthritis, and pancreatic cancer (Deng et al., 2022; Jin et al., 2023). Here, NLRP3 is linked to familial pancreatic carcinoma.